Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

DSP: Pharmas must be open about API suppliers to fight antibiotic resistance

Drug companies need to be more open about their API suppliers to help fight the spread of antimicrobial resistance (AMR) according to DSM Sinochem Pharmaceuticals.

BASF set to start making PVP in China

BASF is poised to start making polyvinylpyrrolidone (PVP) at its facility in Shanghai, China after completing work on a $70m (€62m) manufacturing expansion.

BD injects $100m into Nebraska insulin syringe plant

Becton Dickinson says it is upgrading equipment and technology at its Holdrege manufacturing facility to better serve the global diabetes market.

The end for AbbVie’s bestseller? US FDA approves Amgen’s Humira biosimilar

Amid ongoing patent litigation, the FDA has approved Amgen’s Amjevita: the first US biosimilar version of AbbVie’s top selling rheumatoid arthritis biologic Humira.

Cambrex bolstering API services through $25m PharmaCore acquisition

Cambrex will acquire clinical-scale API maker PharmaCore for $25m adding a standalone GMP facility in North Carolina approved to make Schedule II to V products.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...